AnalystsSam EiberSam Eiber's Stock Forecasts
AnalystsSam Eiber
Analyst Ranking
Top 33%
#1752 out of 5331 analysts
Average Return
+6.44%
Win Rate
53%10 out of 19
Risk vs Reward
Poor
Good
Sam Eiber's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Establishment Labs Holdings IncESTA | +58.07% | $60.51 | $95.65 | 2025-11-05 - 2026-07-21 | Strong Buy |
Establishment Labs Holdings IncESTA | +53.21% | $62.43 | $95.65 | 2026-04-29 - 2026-07-21 | Strong Buy |
Establishment Labs Holdings IncESTA | +49.48% | $63.99 | $95.65 | 2025-11-14 - 2026-07-21 | Strong Buy |
Establishment Labs Holdings IncESTA | +32.79% | $72.03 | $95.65 | 2026-05-07 - 2026-07-21 | Strong Buy |
Establishment Labs Holdings IncESTA | +31.24% | $72.88 | $95.65 | 2025-12-31 - 2026-07-21 | Strong Buy |
Sam Eiber Analyst Color
Get additional color on Sam Eiber's coverage of popular stocks
Sam Eiber's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Brainsway LtdBWAY | 1 | Strong Buy | $18.00 | +11.46% | Initiates Coverage On | 2 days ago |
Neuronetics IncSTIM | 1 | Strong Buy | $5.00 | +165.96% | Initiates Coverage On | 2 days ago |
Evolus IncEOLS | 6 | Strong Buy | $13.00 | +123.94% | Reiterates | a month ago |
Icu Medical IncICUI | 1 | Strong Buy | $170.00 | +7.07% | Initiates Coverage On | a month ago |
Establishment Labs Holdings IncESTA | 6 | Strong Buy | $90.00 | -5.91% | Maintains | 3 months ago |
Apyx Medical CorpAPYX | 1 | Strong Buy | $6.00 | +45.63% | Upgrades | 4 months ago |
Sbc Medical Group Holdings IncSBC | 1 | Strong Buy | $8.00 | +168.46% | Initiates Coverage On | 5 months ago |
Merit Medical Systems IncMMSI | 1 | Strong Buy | $107.00 | +45.62% | Initiates Coverage On | 6 months ago |
Inmode LtdINMD | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.